Patient management by cyclosporine C2 monitoring

被引：6

作者：

Jorga, A

Johnston, A

Holt, DW

机构：

[1] Batts & London, William Harvey Res Inst, London EC1M 6BQ, England

[2] St George Hosp, Sch Med, Analyt Unit, Dept Cardiac & Vasc Sci, London, England

来源：

TRANSPLANTATION | 2004年 / 77卷 / 02期

关键词：

D O I：

10.1097/01.TP.0000101038.20305.C9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：323 / 324

页数：2

共 8 条

[1] Patient management by cyclosporine C2 monitoring: Not enough science yet to justify the practice [J].

Campbell, SB ;

Johnson, DW .

TRANSPLANTATION, 2003, 75 (11) :1917-1918

[2] Comparison of neoral dose monitoring with cyclosporine trough levels versus 2-hr postdose levels in stable liver transplant patients [J].

Cantarovich, M ;

Barkun, JS ;

Tchervenkov, JI ;

Besner, JG ;

Aspeslet, L ;

Metrakos, P .

TRANSPLANTATION, 1998, 66 (12) :1621-1627

[3] Clinical benefit of neoral dose monitoring with cyclosporine 2-HR post-dose levels compared with trough levels in stable heart transplant patients [J].

Cantarovich, M ;

Elstein, E ;

de Varennes, B ;

Barkun, JS .

TRANSPLANTATION, 1999, 68 (12) :1839-1842

[4] BLOOD CYCLOSPORINE CONCENTRATIONS AND RENAL-ALLOGRAFT DYSFUNCTION [J].

HOLT, DW ;

MARSDEN, JT ;

JOHNSTON, A ;

BEWICK, M ;

TAUBE, DH .

BRITISH MEDICAL JOURNAL, 1986, 293 (6554) :1057-1059

[5] Patient management by Neoral C2 monitoring:: An international Consensus statement [J].

Levy, G ;

Thervet, E ;

Lake, J ;

Uchida, K .

TRANSPLANTATION, 2002, 73 (09) :S12-S18

[6] THE VALUE OF THERAPEUTIC DRUG-MONITORING TO THE PRACTICING PHYSICIAN - AN HYPOTHESIS IN NEED OF TESTING [J].

MCINNES, GT .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (03) :281-284

[7] LAKE-LOUISE-CONSENSUS-CONFERENCE ON CYCLOSPORINE ONITORING IN ORGAN-TRANSPLANTATION - REPORT OF THE CONSENSUS PANEL [J].

OELLERICH, M ;

ARMSTRONG, VW ;

KAHAN, B ;

SHAW, L ;

HOLT, DW ;

YATSCOFF, R ;

LINDHOLM, A ;

HALLORAN, P ;

GALLICANO, K ;

WONIGEIT, K ;

SCHUTZ, E ;

SCHRAN, H ;

ANNESLEY, T .

THERAPEUTIC DRUG MONITORING, 1995, 17 (06) :642-654

[8] Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion [J].

Thervet, E ;

Pfeffer, P ;

Scolari, MP ;

Toselli, L ;

Pallardó, LM ;

Chadban, S ;

Pilmore, H ;

Connolly, J ;

Buchler, M ;

Schena, FP ;

Carreno, CA ;

Dandavino, R ;

Cole, E .

TRANSPLANTATION, 2003, 76 (06) :903-908

← 1 →